» » »

Lung Cancer Treatments Omaha NE

Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found.

Aaron R Sasson
(402) 559-9800
988095 Nebraska Medical Ctr
Omaha, NE
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Stefano Tarantolo, MD
(402) 559-5520
8303 Dodge St Ste 250,
Omaha, NE
Specialties
Internal Medicine, Medical Oncology
Gender
Male
Education
Medical School: St George'S Univ, Sch Of Med, St George'S, Grenada
Graduation Year: 1985
Hospital
Hospital: N H S Univ Nebraska Med Ctr, Omaha, Ne
Group Practice: University Medical Associates Univ Of Nebraska Medical Ctr

Data Provided by:
R Gregory Bociek, MD
(402) 559-5600
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ottawa, Fac Of Med, Ottawa, Ont, Canada
Graduation Year: 1988

Data Provided by:
George Philamon Hemstreet, MD
(402) 559-4627
982360-2360 Nebraska Medical Center,
Omaha, NE
Specialties
Urology, Medical Oncology
Gender
Male
Education
Medical School: Hahnemann Univ Sch Of Med, Philadelphia Pa 19102
Graduation Year: 1968
Hospital
Hospital: N H S Univ Nebraska Med Ctr, Omaha, Ne; Veterans Affairs Medical Ctr, Omaha, Ne
Group Practice: University Medical Assoc

Data Provided by:
Harold M Maurer
(402) 559-9800
988095 Nebraska Medical Ctr
Omaha, NE
Specialty
Pediatric Hematology-Oncology

Data Provided by:
Harold Maurice Maurer, MD
(402) 559-4200
986605 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1961
Hospital
Hospital: Clarkson Memorial Hosp, Omaha, Ne; N H S Univ Nebraska Med Ctr, Omaha, Ne; Childrens Mem Hosp, Omaha, Ne
Group Practice: University Medical Associates Univ Of Nebraska Medical Ctr

Data Provided by:
Lori Jo Maness, MD
(402) 559-3742
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Suny-Hlth Sci Ctr At Syracuse, Coll Of Med, Syracuse Ny 13210
Graduation Year: 1997

Data Provided by:
Natarajan V Raman
(402) 559-9800
988095 Nebraska Medical Ctr
Omaha, NE
Specialty
Radiation Oncology

Data Provided by:
Alfred Carlos Grovas, MD
(402) 559-7257
982168 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ne Coll Of Med, Omaha Ne 68198
Graduation Year: 1985

Data Provided by:
Aparkishor Prakashrao Ganti, MD
(402) 559-6210
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Bj Med Coll, Univ Of Pune, Pune, Maharashtra, India
Graduation Year: 1996

Data Provided by:
Data Provided by:

Lung Cancer Treatments

Provided By:

MONDAY, July 27 (HealthDay News) -- Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found.

Stage 3A is declared when surgery cannot cure the disease because it has spread to the lymph nodes in the center of the chest.

Non-small-cell lung cancer accounts for about 80 percent of lung cancers, and smoking tobacco is the most common cause of lung cancer. According to the U.S. National Cancer Institute, the risk of lung cancer is linked to the earlier in life a person starts smoking, the more often a person smokes and the more years a person smokes.

For the study, a research team led by Dr. Kathy Albain of Loyola University Chicago Stritch School of Medicine in Maywood, Ill., compared 202 patients who underwent chemotherapy plus radiotherapy followed by surgery with 194 patients who underwent chemotherapy plus radiotherapy alone, which is the current standard for these patients.

The researchers looked at the overall survival rates of the 396 patients after five years to draw their conclusions. They found no statistically significant difference in overall survival.

In an exploratory analysis, the researchers found that overall survival did improve for patients who only had part of a lung removed (lobectomy) rather than an entire lung. They speculated that removing an entire lung left patients more likely to die from acute respiratory distress syndrome or other respiratory diseases.

"On the basis of the findings of our study, patients should be counseled about the risks and potential benefits of definitive chemotherapy plus radiotherapy with, and without, a surgical resection (preferably by lobectomy)," the authors concluded.

The findings appear in the July 27 online edition of The Lancet.

More information

Learn more about non-small-cell lung cancer from the U.S. National Cancer Institute.

SOURCE: The Lancet, news release, July 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com